RDYN - Replidyne, Inc. IPO Opens for Trading
29 June 2006RDYN - Replidyne, Inc. priced yesterday (06/28/06) at $10.00 (below its initial $14-16 range), opened at $10.00 and closed at $10.10, up $0.10 (+1.00%). Replidyne is a biopharmaceutical company focused on discovering, developing, in-licensing and commercializing innovative anti-infective products and is currently developing Orapem, an oral antibiotic developed to treat respiratory and uncomplicated skin infections in adults and kids. URL - http://www.replidyne.com
Leave a reply
You must be logged in to post a comment.
